Back to
EARNEST PARTNERS LLC
CRL30 quarters
Position history for
EARNEST PARTNERS LLC's holdings in Charles River Laboratories Int
EARNEST PARTNERS LLC holds 1.1M shares of CRL (Charles River Laboratories Int), worth $254M as of 2026-Q2. The position was increased (+15.3% shares). CRL represents 0.9% of EARNEST PARTNERS LLC's portfolio.
Current Value
$254M
Current Shares
1.1M
Total Value Change
+$219M
Total Shares Change
+879,169
Quarter-by-Quarter History
Other major holders of CRL: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., VANGUARD GROUP INC